3D printed prosthetics are artificial devices that replace a missing body part and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types in the 3D printed medical prosthetics are sockets, limbs, joints, covers, and others. The prosthetic limbs are used as artificial limbs for those who need limbs. These are made up of various materials such as polypropylene, polyethylene, acrylics, and polyurethane. These are used by end-users such as hospitals, rehabilitation centres, and prosthetic clinics. The 3D printed medical prosthetics market research report is one of a series of new reports from The Business Research Company that provides 3D printed medical prosthetics market statistics, including 3D printed medical prosthetics industry global market size, regional shares, competitors with a 3D printed medical prosthetics market share, detailed 3D printed medical prosthetics market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed medical prosthetics industry. This 3D printed medical prosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global 3D printed prosthetics market size will grow from $0.96 billion in 2022 to $1.04 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global 3D printed prosthetics market size is expected to grow to $1.44 billion in 2027 at a CAGR of 8.4%. The rising number of accidental injuries is driving the growth of the 3D printing prosthetic devices market. Accidental injuries can cause serious damage to a person, and these injuries can sometimes lead to amputation. In2021, car crashes in the US resulted in the death of 42915 people which was the highest in 16 years. According to a report from National Centre for Health Statistics, approximately 50,000 new amputation cases come up each year in the US. An increase in incidences of other medical conditions such as diabetes and vascular diseases is also leading to a rise in amputation cases, thus boosting the sales of 3D printing prosthetics. For instance, according to a report published in the American Journal of Managed Care, it was estimated that, globally, one patient leg is amputated every 30 seconds and around 85% of these amputations were a result of a diabetic foot ulcer. The delay in elective procedures attributed to the coronavirus outbreak is to act as a major factor to limit the growth of the 3D printed medical prosthetics market. Many countries and hospitals have diverted their healthcare resources to deal with COVID-19 patients. For instance, according to the Centers for Medicare & Medicaid Services (CMS) safety guidelines released in March 2020, all the elective and non-essential surgical, dental, and medical procedures are delayed in the USA during the 2019 Novel Coronavirus (COVID-19) outbreak. Hence, the delays in surgical or elective procedures are projected to decline the demand for the 3D printed medical prosthetics market shortly. Companies in the 3D printing prosthetics market are focusing on the development of waterproof prosthetic devices. The aim behind this innovation is to provide the user with an increased range of mobility, especially in athletics. In October 2020, Braskem, Americas leading producer of biopolymers has launched Braskem e-NABLE Chapter for Philanthropic Creation of 3D Printed Prosthetic Devices. Braskem was selected to be certified to produce the e-NABLE Phoenix V3 prosthetic hand as it is one of the most commonly produced e-NABLE prosthetic devices. Major players in the 3D printing medical prosthetics market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Bionicohand, YouBionic, UNYQ, Mercurys, LimbForge Inc., Open Bionics, Protosthetics, and Create Prosthetics. North America was the largest region in the 3D printing medical prosthetics market in 2022. Asia-Pacific was the second-largest region in the global 3D printed prosthetics market. The regions covered in global 3D printed prosthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printing medical prosthetics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed prosthetics market consists of sales of 3D printed instruments such as sockets, limbs, joints, covers, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global 3D printed prosthetics market is segmented - 1) By Material: Polypropylene, Polyethylene, Acrylics, Polyurethane 2) By Type: Sockets, Limbs, Joints, Covers, Other Types 3) By End-User: Hospitals, Rehabilitation Centers, Prosthetic Clinics

3D medical imaging is a cutting-edge optical imaging technology that produces enlarged images of the interior of the body for medical examination. 3D medical imaging is used to create three dimensions’ visual representation of interior body parts for medical analysis with the help of computer-aided design (CAD) or a magnetic resonance image (MRI). The main types in 3D medical imaging are ultrasound, X-ray, CT scan, and others. The x-rays are used to capture images that are 2D and create the illusion of 3D x-ray imaging. The various applications are gynecology and obstetrics, cardiology, neurology, orthopedics, and oncology that are used by various end-users such as diagnostic centres, hospitals, and research centres. The 3D medical imaging market research report is one of a series of new reports from The Business Research Company that provides 3D medical imaging market statistics, including 3D medical imaging industry global market size, regional shares, competitors with a 3D medical imaging market share, detailed 3D medical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the 3D medical imaging industry. This 3D medical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global 3D medical imaging devices market size will grow from $15.36 billion in 2022 to $16.27 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global 3D medical imaging devices market size is expected to grow to $20.45 billion in 2027 at a CAGR of 5.9%. Increasing cases of injuries such as sports-related injuries contribute to the growth of the 3D medical imaging market. The increase in sports-related injuries is due to the increasing participation of individuals in organized and unorganized sports activities. Moreover, the training of athletes with high strength and high load also results in more and more serious injuries. Sports injuries are mainly characterized by soft tissue injury. The use of 3D medical imaging devices such as ultrasound diagnosis, X-ray radiography, MRI imaging provides an accurate and objective basis for the diagnosis. The 3D medical imaging devices help in the examination of muscle fascia injury, tendon injury, ligament injury, meniscus injury, articular cartilage, and bone fracture. According to the Centre for the Disease Control and Prevention, it is estimated that there are 775,000 emergency room visits due to the injuries in children who are participating in unorganized and organized sports activities. Thus, the increase in demand for 3D medical imaging devices favors the market growth. The difficulties faced by the medical device industry owing to the COVID-19 outbreak such as the slowdown in orders and supply chain disruptions are likely to restraint the growth of the 3D medical imaging market over the next coming years. According to Medical Products Outsourcing (MPO) magazine published in April 2020, financial strains and supply chain disruptions are the major challenges faced by the medical devices industry. The manufacturers are experiencing a modest slowdown in orders attributed to tight management of inventories due to fear of the spread of the virus and slow pace of reorders owing to the impact of the virus on businesses. Moreover, the managers are also hesitant in overseeing the new product launches in uncertain times. This scenario is predicted to act as a major factor restraining the growth of the market shortly. 3D medical imaging device manufacturers are increasingly investing in Artificial Intelligence (AI) to improve the diagnosis by giving accurate, hard-number measurements. AI provides efficiency in medical imaging, particularly when it comes to detecting organs or anomalies. For instance, by combining image visualization and AI, cardiologists can measure ejection fraction with high precision and in a much shorter period. Ejection fraction is a measurement of the percentage of blood leaving the heart each time it contracts. For instance, In November 2021, GE Healthcare, a company operating in 3D imaging devices unveiled 60 innovative technology solutions including artificial intelligence to transform healthcare to help patients and clinicians with an effective way of solutions. In February 2020, Alphatec Holdings, Inc. (ATEC or the Company) acquired EOS imaging, SA for a purchase price of about $88 million. With this acquisition, ATEC will integrate spine imaging and anatomical modeling for better operative performance and is expected to significantly increase the demand for ATEC hardware and EOS systems. EOS Imaging is a France-based medical device company leading in orthopedic medical imaging solutions. Major players in the 3D medical imaging market are GE Healthcare, Royal Philips, Siemens AG, The Esaote Group, Intrasense SA, Materialize NV, Toshiba Group, Samsung Medison Co. Ltd., Shimadzu Corporation, and Analogic Corporation. Western Europe was the largest region in the 3D medical imaging market in 2022. Asia-Pacific was the second-largest region in the global 3D medical imaging devices market. The regions covered in the global 3D medical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D medical imaging market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D medical imaging market consists of sales of ultrasound, magnetic resonance imaging (MRI), radiography, and computed tomography scan (CT). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global 3D medical imaging devices market is segmented - 1) By Type: Ultrasound, X-ray, CT Scan, Other Types 2) By End User: Diagnostic Centers, Hospitals, Research Centers 3) By Application: Gynecology and Obstetrics, Cardiology, Neurology, Orthopedics, Oncology

3D diagnostic imaging services include optical imaging of body to visualize internals of body in 3D. These services are used for diagnostic purposes. 3D Diagnostic imaging enables medical professionals to probe within your body in search of signs of a disease. The main techniques of 3D diagnostic imaging services are ultrasound, MRI, X-ray, computed tomography, others. An ultrasound is a type of imaging test that utilizes sound waves to create images of organs, tissues, and other structures within the body. The various applications include oncology, cardiology, orthopedics, and others that are used by diagnostic centers, hospitals and research centers. The 3D diagnostic imaging services market research report is one of a series of new reports from The Business Research Company that provides 3D diagnostic imaging services market statistics, including 3D diagnostic imaging services industry global market size, regional shares, competitors with a 3D diagnostic imaging services market share, detailed 3D diagnostic imaging services market segments, market trends and opportunities, and any further data you may need to thrive in the 3D diagnostic imaging services industry. This 3D diagnostic imaging services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global 3d diagnostic imaging services market will grow from $195.51 billion in 2022 to $207.38 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global 3d diagnostic imaging services market is expected to grow to $262.32 billion in 2027 at a CAGR of 6.1%. The demand for point-of-care testing (PoCT) has been steadily increasing over the years. The growth in demand is likely to continue and drive the market for 3D diagnostic imaging services market. This is because PoCT allows physicians and medical staff to accurately achieve real-time, lab-quality diagnostic results within minutes rather than hours. Also, the changing healthcare delivery system is aimed at delivering cost effective care at patient’s home. In most of the countries, especially developing countries, more effective care for infectious diseases is needed. PoCT technologies provide effective care with easy-to-use devices and improved analytical performance and recent improvements in the speed, usability and affordability of medical imaging with 3D integration have greatly expanded the capabilities of PoCT testing systems. These advances are greatly driving the 3D diagnostic imaging services market. The 3D diagnostic imaging services market is constrained by the shortage of qualified and skilled healthcare resources. The main reasons are the aging workforce, the complexity of the latest procedures and their reluctance towards learning the new procedures, and shrinking number of accredited training programs. According to the WHO, there will be a shortage of 18 million health workers by 2030, with the majority of this personnel coming from low- and lower-middle-income countries. The shortage of skilled workforce is expected to affect the 3D diagnostic imaging services market. Therefore, there is an urgent need to train more healthcare professionals in the latest procedures and technologies including 3D imaging to enable accurate diagnosis and treatment in the most efficient manner. Introduction of improved data storage and information sharing systems such as medical cloud technology is creating more growth opportunities for 3D diagnostic imaging. This is because medical imaging requires adequate resources to process, store, exchange and use large quantities of medical data for appropriate diagnostic and treatment decisions, and advanced cloud computing in medical imaging addresses these concerns. Cloud computing is an emerging solution for questions related to delivering complex services and data interchange over the internet. Cloud computing technology enables medical data sharing across regions, allowing more patients to obtain the medical resources they need. It allows easy retrieval of data and provides doctors with more convenient clinical image data services (clear and informative images). Medical cloud imaging has become an important field of cloud computing. In January 2020, Metropolis Healthcare, a chain of diagnostic companies, acquired a 51% stake in Shraddha Diagnostic Centre for Rs 9.36 crores ($1.27 million). This acquisition helps Metropolis Healthcare expand its geographical reach into nine cities and towns in India. Shraddha Diagnostics is a private company that primarily serves the B2B segment. Major players in the 3D diagnostic imaging services market are Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Alere Inc., Bio-Reference Laboratories, DaVita Healthcare Partners Inc., Genomic Health Inc., Myriad Genetics Inc., NeoGenomics Inc., Sonic Healthcare Limited, Spectra Laboratories, and SYNLAB International GMBH.  North America was the largest region in the 3D diagnostic imaging services market in 2022. Western Europe was the second largest region in the global 3D diagnostic imaging services market. The regions covered in the global 3D diagnostic imaging services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the 3D diagnostic imaging services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The 3D diagnostic imaging services market includes revenues earned by entities by providing PET, sonography, and mammography services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global 3D diagnostic imaging services market is segmented - 1) By Technique: Ultrasound, MRI, X-ray, Computed Tomography, Other Techniques 2) By Application: Oncology, Cardiology, Orthopedic, Other Applications 3) By End User: Diagnostic Centers, Hospitals, Research Centers

Hearing implants are surgically installed devices aimed at improving the hearing capability of a person suffering from severe or profound levels of hearing loss. The main types of hearing implants devices and equipment are cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants. A cochlear implant is an electronic device that partially restores hearing. It is an option for people who have severe hearing loss from inner-ear damage and are no longer helped by using hearing aids. These are used by age groups such as adults and pediatrics. The various end-users are hospitals, ENT clinics, and ambulatory surgical centres. The hearing implants devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing implants devices and equipment market statistics, including hearing implants devices and equipment industry global market size, regional shares, competitors with a hearing implants devices and equipment market share, detailed hearing implants devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing implants devices and equipment industry. This hearing implants devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hearing implants market size will grow from $3.95 billion in 2022 to $4.4 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hearing implants market size is expected to grow to $6.36 billion in 2027 at a CAGR of 9.7%. The aging population is increasing worldwide and loss of hearing is one of the most common age-related disorders in the aged above 60 years. As reported by United Nations, in 2020, there are 727 million people aged 65 years in the world and with the increasing geriatric population, the demand for hearing implants is expected to rise. Therefore, the increasing aging population is expected to drive the market for hearing implants in the future. The surgical procedure for implanting hearing implants is associated with various risks and is expected to restraint the market growth in the future. During the surgery, there are possibilities of facial nerve damage which can lead to complete or partial paralysis on the same side of the face as the implant. Due to this and other complications such as the development of meningitis, cerebrospinal fluid leakage, infection, and others, people prefer conventional hearing aids over implants. Hence, restraining the growth of the hearing implants market. Companies in the hearing implants market are making implants using 3D printing in binaural cochlear surgeries. The technology focuses on developing customized 3D printed implants using biocompatible materials to treat anatomical defects with the help of stem cells. Sonova manufactures binaural cochlear implants, which use two different modes of stimulation, electrical and acoustic to enhance hearing and better discrimination of speech. Further, in 2020, scientists developed a 3D-microscaffold cochlear implant using a 3D printed steroid reservoir was designed to reduce the damage of residual hearing against electrode insertion trauma. Cochlear implant manufacturers have to submit information regarding the material used, efficacy based on clinical trials, any adverse effects to the FDA. The manufacturer can begin the sale of the implants in the USA only after receiving approval from the FDA. Major players in the hearing implants devices and equipment market are Sonova (Switzerland), Advanced Bionics AG (Switzerland), Siemens AG, William Demant Holding Group (Denmark), Microson S.A. (Spain), RION, SeboTek Hearing Systems, Arphi Electronics, Widex A/S, and Audina Hearing Instruments. North America was the largest region in the global hearing implants devices and equipment market in 2022. Asia-Pacific was the second-largest region in the hearing implants devices and equipment market. The regions covered in the global hearing implants devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing implants devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing implants market consists of sales of cochlear implants, bone anchored hearing aids (BAHA), mid-ear implants, and auditory brainstem implants (ABI) that are used to improve hearing capability. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hearing implants market is segmented - 1) By Type: Cochlear Implants, Middle Ear Implants, Bone Conduction Implants, Auditory Brainstem Implant 2) By End-User: Hospitals, ENT clinics, Ambulatory Surgical Centres 3) By Age: Adult , Pediatric

Spine implants are the devices used to correct the deformity in the spine, stabilise and strengthen the spine, and facilitate the fusion of bones in different disorders such as degenerative disc disease, kyphosis, scoliosis, spondylolisthesis, spinal stenosis, and fracture. The main products in the spine implant market are spinal fusion devices, non-fusion devices/motion preservation devices, vertebral compression fracture (VCF) treatment devices, spinal bone stimulators, and spine biologics. The spinal fusion devices provide a solution for spinal instability and are designed specifically to treat spinal disorders. They use surgical procedures to implant titanium-alloy, titanium, stainless steel, and non-metallic devices into the spine. Open surgery and minimally invasive surgery (MIS) are among the procedures involved.The various materials in spine implants include metallic, polymeric, and ceramic. The spinal implants are used in hospitals, specialty orthopaedic and spine centres, and ambulatory surgical centres. The spine implants market research report is one of a series of new reports from The Business Research Company that provides spine implants market statistics, including spine implants industry global market size, regional shares, competitors with a spine implants market share, detailed spine implants market segments, market trends and opportunities, and any further data you may need to thrive in the spine implants industry. This spine implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global spine implants market grew from $11.32 billion in 2022 to $12.33 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The spine implants market is expected to grow from $16.86 billion in 2027 at a CAGR of 8.1%. The rising incidences of spinal disorders coupled with the usage of minimally invasive surgical procedures are contributing to the growth of the global spinal implants market. According to Branko PRPA, surgical in September 2021, annually there are 1.34 to 4.6 spinal cases per million and 1,400 new cases diagnosed each year, with 33,000 having some type of disability in the US and among them, 30% of the adult female population suffers from lower back pain, compared to 25 percent of the adult male adult population and this is approximately 31% of men acknowledged that their condition affects their employment compared to 20% of women. In 2021, the prevalence of neuropathic pain was found to be between 16% and 55%. And due to the emergence of minimally invasive spine surgical (MISS) approaches, it has now become feasible and efficient for treating a wide range of spinal disorders without long incisions and by avoiding significant damage to muscles surrounding the spine, thereby resulting in fewer post-operative pains and faster recovery. Therefore, the increased prevalence of spinal disorders along with the ease in treatment by MISS approaches is driving the global spinal implants market. The increased treatment procedural cost is acting as a hindrance to the global spinal implants market growth. According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US. The cost of spinal surgeries has increased by 175% globally and in the US, the annual cost of spine care is estimated at $105 billion per patient annually. Increased treatment procedural costs will increase monetary concerns, limiting the market growth. The innovation of implants in providing minimally invasive and motion-preserving stabilization is a major trend in the spine implants market. For example, RTI Surgical Holdings, a global surgical implant company, has launched the first and only posterior lumbar motion preservation solution, Coflex. Coflex is a differentiated, minimally-invasive, motion-preserving stabilization implant that is FDA PMA-approved for the treatment of moderate to severe lumbar spinal stenosis (LSS). It can be directly implanted following a surgical decompression, without fusing the bones. The device comes in different sizes to fit the patient’s anatomy, and this can be performed even in an outpatient setting. In July 2022, Spineway, a France-based spinal implants manufacturer acquired Spine Innovations for an undisclosed amount. The acquisition would help Spineway to accelerate its innovation and growth and position itself as a leader in this segment. Spinal Innovations is a French manufacturer of spinal implants. Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc., Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical. North America was the largest region in the spine implants market in 2022. Western Europe was the second largest region in the global spine implants market report. The regions covered in the global spine implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the spine implant market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The spine implants market consists of sales of cages, plates, rods values, artificial disc and expandable rods. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global spine implants market is segmented - 1) By Product: Spinal Fusion Devices, Non-Fusion Devices/Motion Preservation Devices, Vertebral Compression Fracture (VCF) Treatment Devices, Spinal Bone Stimulators, Spine Biologics 2) By Procedure: Open Surgery, Minimally Invasive Surgery (MIS) 3) By Material: Metallic, Polymeric, Ceramic 4) By End Use: Hospitals, Specialty Orthopedic And Spine Centers, Ambulatory Surgical Centers

Dental implants are medical devices surgically implanted into the jaw to restore a person's ability to chew or their appearance. The main products of dental implants are tapered implants and parallel walled implants. A tapered implant is a cylindrical implant in which the endosseous part is narrow in diameter towards the apex. The dental implants are made up of materials such as titanium and zirconium that are used by various end-users, such as hospitals and dental clinics. The dental implants market research report is one of a series of new reports from The Business Research Company that provides dental implants market statistics, including dental implants industry global market size, regional shares, competitors with a dental implants market share, detailed dental implants market segments, market trends and opportunities, and any further data you may need to thrive in the dental implants industry. This dental implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global dental implants market grew from $6.21 billion in 2022 to $6.86 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dental implants market is expected to grow from $9.85 billion in 2027 at a CAGR of 9.4%. The rising prevalence of dental caries that require dental implants for treatment increase the demand for dental implants. Dental caries is a multifactorial, chronic condition arising from various causes such as nutrition, saliva, micro-organisms, trace minerals, genetic predisposition, and tooth morphology leading to tooth decay. According to a research survey published on BMC healthcare research, an open access research article publisher, in 2021, the prevalence of dental caries in primary and permanent teeth was found to be 41.1% and 68.9% respectively. Dental implants have also become popular as an alternative to removable dentures and are used to replace lost teeth. As a result, the increasing demand for dental implants to replace lost teeth stimulates market growth. The high cost of dental implants is a key factor hampering the growth of the dental implants market. Dental implants are a form of dental surgery that involves multi-stage surgery and are one of the costliest dental procedures to repair false teeth. For instance, dental implants cost an average of between $3,000-$4,500 per tooth in the USA, including total implant size, abutment and crown, and bone graft, which is often needed, cost an additional $200-$3,200. The high cost of dental implants makes them unaffordable for medium and low-income groups obstructing the growth of the dental implants market. Dental implant technology has advanced with the introduction of new technologies and equipment, which improve the consistency and quality of implant treatment. Companies are manufacturing implants that suit the patients’ aesthetics. For instance, in June 2022, ZimVie launched T3 Pro Tapered implant and Encode® Emergence Healing Abutment. The products were designed keeping in mind the products provide both restorative care and aesthetics as well. In 2020, Keystone Dental, a US-based dental implant company, acquired Osteon Medical for an undisclosed amount. This acquisition is providing Keystone with a synergistic sales opportunity to expand in the $5 billion dental implant market. Osteon Medical is an Australia-based company manufacturer of dental implants. Major players in the dental implants market are Zimmer Biomet Holdings Inc., OSSTEM IMPLANT, Institut Straumann AG, Bicon LLC, DENTSPLY Sirona, Danaher Corporation, BioHorizons IPH Inc., Shofu Dental Corporation, Thommen Medical AG, and Ivoclar Vivadent Inc. Asia-Pacific was the largest region in the dental implant market in 2022. Western Europe was the second-largest region in the global dental implant market report. Africa. was the smallest region in the global dental equipment and supplies market. The regions covered in the global dental implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the dental implants market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. Dental implants consist of sales of implants such as endosteal implants, subperiosteal implants, and transosteal implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global dental implants market is segmented - 1) By Product: Tapered Implants, Parallel Walled Implants 2) By Material: Titanium, Zirconium 3) By End-use: Hospitals, Dental Clinics

Cranial implants are used for protecting intracranial structure, reconstructing the skull shape, normalizing cerebral hemodynamics, and also during cranial reconstruction procedures after cranial defects. The main types of cranial implants include customized and non-customized cranial implants. A customized implant is transplanted into the wound and then transforms its shape when the temperature, pressure, or magnetic field changes, to adapt to the dimensions of tissue defects. A polymer is a large molecule or a macromolecule which essentially is a combination of many subunits. The main types of material used for manufacturing cranial implants are polymer, metal, and ceramic and are used in hospital and trauma centers, ambulatory surgical centers, speciality clinics, and others. The cranial implants market research report is one of a series of new reports from The Business Research Company that provides cranial implants market statistics, including cranial implants industry global market size, regional shares, competitors with a cranial implants market share, detailed cranial implants market segments, market trends and opportunities, and any further data you may need to thrive in the cranial implants industry. This cranial implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global cranial implants market size grew from $1 billion in 2022 to $1.1 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cranial implants market size is expected to grow to $1.45 billion in 2027 at a CAGR of 7.1%. The rising prevalence of neurological diseases and road accidents is expected to propel the growth of the cranial implants market in the forecast period. According to Parkinson's disease statistics, Parkinson's disease is the second most common age-related neurological disorder after Alzheimer's disease. A cranial implant will enable doctors to look inside the brain without having to drill a new hole in the skull each time, making neurological disorder treatment easier. According to Parkinson's Foundation, in 2020, approximately one million cases were suffering from Parkinson's disease (PD) in the U.S. According to the world health organization, approximately 1.35 million people die every year from road accidents. Accidents cause a skull fracture, brain damage, and other related conditions. Therefore, the rising prevalence of neurological diseases and road accidents is driving the growth of the cranial implants market. 3D printing is an emerging technology in the cranial implants market. 3D printing is the method of making three-dimensional solid objects from digital data. For instance, in 2020, Graz University of Technology (TU Graz) and the Medical University of Graz in Austria, released a free automated design software to design 3D printable cranial implants. The program utilizes deep learning algorithms to automatically replace the missing portion of a skull. An STL file for a patient-specific implant can immediately be generated by decreasing the defective skull from the performed one. This process allows implants to be 3D printed on-site and drastically reduces the actual lead time. In July 2020, Medtronic plc, a US-based medical device company that offers surgical devices, respiratory monitoring systems, medical equipment, and other equipment acquired Medicrea for a value of $ 8.2 (€7.00) per Medicrea share. This acquisition would increase Medtronic’s position as a global innovator in licensing technologies and solutions for spine surgery. Medicrea is a US manufacturer of medical devices and offers a variety of implants for the cervical spine and bone substitutes for the thoracic spine. Major players in the cranial implants market are B. Braun Melsungen AG, DePuy Synthes (Johnson and Johnson), Stryker Corporation, Zimmer Biomet, Kelyiniam Global Inc., Medartis AG, Osteomed, KLS Martin Group, Renishaw PLC., Xilloc Medical B.V., Medtronic, Ortho Baltic, Evonos, and Synimed. North America was the largest region in the cranial implants market in 2022. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cranial implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cranial implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The cranial implants market consists of sales of titanium implants, synthetic bone implants, and solid biomaterials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cranial implants market is segmented - 1) By Type: Customized Cranial Implants, Non-customized Cranial Implants 2) By Material: Polymer, Ceramic, Metal 3) By End User: Hospital and Trauma Centers, Ambulatory Surgical Centers, Speciality Clinics, Other End-Users

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices